PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: CHUSEI (USA), Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Phyto-Source, L.P. Phytosterol Capacity Expansion - Phyto-Source, L.P., one of the world’s leading suppliers of high purity non-GMO wood (plant) derived sterols, announced today an increase in capacity of their manufacturing facility in Houston, Texas
Phyto-Source, L.P. Phytosterol Capacity Expansion

 

NewswireToday - /newswire/ - Houston, TX, United States, 2007/01/27 - Phyto-Source, L.P., one of the world’s leading suppliers of high purity non-GMO wood (plant) derived sterols, announced today an increase in capacity of their manufacturing facility in Houston, Texas.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Phyto-Source’s plant capacity has been successfully increased by over forty percent to meet the increased demand for the company’s cholesterol-lowering food ingredient, Phyto-S-Sterol™. The increased capacity has been achieved through process debottlenecking initiatives, technology improvements, and capital additions.

Bill Sonnier, President and CEO of Chusei (USA) and Manager of Phyto-Source, notes that “this recent expansion of our ability to produce high quality phytosterols is just the first step in our goal to significantly increase our production volume and capabilities. There will be further expansion of capacity and product varieties at our Houston facility in the near term. We are also moving forward with plans to build a major manufacturing plant in Europe so that we can better serve that market’s growing need for phytosterols.”

Sonnier went on to say “Phyto-Source is well positioned to meet the requirements for new applications and customers in the sterol marketplace. The global market for phytosterols is expanding and Phyto-Source is prepared for this development through the application of is proprietary, state-of-the-art technology. By expanding our capacity in Houston and building new capacity in Europe, Phyto-Source will continue to build its leadership position”

Phyto-Source, L.P. (phytosourcelp.com) is a leading producer of high-quality non-Genetically Modified (non-GM) wood (plant) sterols and serves a growing list of customers around the world.

Chusei (U.S.A.) Inc. (chuseiusa.com) serves the custom chemical manufacturing industry through its manufacturing facility located in the Houston, Texas area. Chusei also serves as the operating partner for Phyto-Source, L.P.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: CHUSEI (USA), Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Phyto-Source, L.P. Phytosterol Capacity Expansion

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Thomas Stegmann - PhytoSourceLP.com 
281-291-7990 x18 tom.stegmann[.]phytosourcelp.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any CHUSEI (USA), Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From CHUSEI (USA), Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)